Coherus Oncology (CHRS)'s 30-day implied volatility (IV30) was 93.6% at the close on November 17, 2026, up from 91.8% the day before, against a 52-week range of 51.5% to 180.0%. Its 20-day historical volatility was 105.8%.
Data as of November 17, 2026.